Jeffrey Finer

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Raised $250,000,000.00 from Vertex Ventures HC, Soleus Capital, Biotechnology Value Fund, Driehaus Capital Management, Invus, Catalio Capital Management, RA Capital Management, Woodline Partners, Third Rock Ventures and Goldman Sachs Asset Management.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Raised $496,000,000.00 from Logos Capital, Frazier Life Sciences, Janus Henderson Investors and Deep Track Capital.

Strateos is a SaaS-based biotechnology company that provides robotic solutions for biology labs.

Raised $105,769,999.00 from Alumni Ventures, Black Diamond Ventures, StreShi, Ally Bridge Group, Mack-Cali Realty Corporation, Dolby Family Ventures, AME, Castor Ventures, Harmonix Fund and Lux Capital.

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

Raised $187,000,000.00 from Takeda, Smilegate Investment, Third Rock Ventures, Laurion Capital Management, Alexandria Venture Investments, Schroders Capital, Takeda Ventures and Third Rock Ventures.

Theravance Biopharma is a biopharmaceutical company with one approved product.

Raised $663,200,000.00 from Woodford Investment Management.

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

Raised $1,760,450,000.00 from Royalty Pharma, Deerfield, Federated Kaufmann Fund and Red Abbey Venture Partners.

Massachusetts Eye and Ear Infirmly is the hospital specializing in research, education and treatment of eye and ear.